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Background: Blastocystis, is one of the most common human intestinal protozoan, which has many conflicting
reports on its pathogenic role. Gut conditions which obviously varies in asymptomatic individuals, symptomatic and
irritable bowel syndrome (IBS) patients in terms of gut flora, pH, osmotic pressure and water potentials could play
an important role in its pathogenicity. The present study is the first study to investigate phenotypic characteristics
of Blastocystis sp. ST3 isolated from asymptomatic, symptomatic and IBS isolates.
Methods: A total of 8 Blastocystis isolates were obtained from four IBS patients (IBS1-4) and four symptomatic
patients (S1-4) at a local gastroenterology clinic. Asymptomatic isolates (A1-4) were obtained from a field survey at
a local village.
Results: All 12 isolates were determined as subtype 3 (ST3). A1-4 isolates showed the highest peak growth followed
by IBS1-4 isolates and S1-4 isolates for the growth profile. Parasites from IBS isolates (IBS1-4) showed the largest
diameter with a mean 18.43 ± 2.22 μm compared to parasites of symptomatic isolates (isolates S1-4) 15.54 ± 3.02
μm and asymptomatic isolates (isolates A1-4) 11.76 ± 0.82 μm. The symptomatic isolates (average generation time:
9.87 ± 2.97 h) grew faster than the IBS isolates (average generation time: 7.56 ± 1.06 h) and asymptomatic isolates
(average generation time: 5.97 ± 1.52 h). The parasites isolated from IBS isolates showed strong aggregation and
clumping, which had seen reduced in parasites of isolates S1-4. No clumping was seen in parasites from A1-4. The
outer surface of parasites in IBS isolates showed greater binding affinities towards FITC-labelled Concanavalin A
(Con A) than symptomatic isolates and asymptomatic isolates. Scanning electron microscopy showed that in IBS
isolates, the surface of Blastocystis showed a very coarse and intensely folded surface. The IBS isolates also exhibited
a dense material and a thicker layer of surface coat can be seen compared to asymptomatic and symptomatic
isolates.
Conclusion: There have been no studies thus far providing evidence for phenotypic variation within a particular
subtype. The present study is the first to demonstrate the phenomenon of gut environment facilitating adaptation
of parasites possibly for survival leading to phenotypic differences for Blastocystis.
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Blastocystis, the most common human intestinal proto-
zoan [1], has the fecal-oral route as the usual mode of
transmission with its infective stage being the cyst form
[2]. Although clinical signs of Blastocystis infection have
been shown to be mainly diarrhoea, abdominal pain as
well as non-specific gastrointestinal symptoms such as
nausea, anorexia, vomiting, weight loss, lassitude, dizzi-
ness, and flatulence [3], however the conflicting reports
on its pathogenic role still continues with the organism* Correspondence: suresh@um.edu.my
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any symptoms.
Phenotypic differences between symptomatic and asymp-
tomatic isolates have been also shown through isoenzyme
patterns [4,5], protein profiling and [6,7] sero-groups [8]
and molecular characterization [9-16]. A recent study re-
ported that solubilized antigen of Blastocystis (Blasto-Ag)
derived from symptomatic isolates was more pathogenic
and possess the ability to weaken the cellular immune
response compared to the asymptomatic isolates [17].
There have been 13 subtypes reported [15] with
Blastocystis ST3 shown to be the highest in Thailand
with prevalence rates between 41.7-92.3% [18]; Egypt-
54.55% [19]; Singapore- 78% [20]; Turkey- 75.9% [21];l Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
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[23]. These studies demonstrate the importance of subtype
3 in terms of its prevalence and its pathogenic implications.
Blastocystis had been associated with irritable bowel
syndrome (IBS) [24] and the consequence of gut condi-
tions which obviously varies in asymptomatic individ-
uals, symptomatic and IBS patients in terms of gut flora,
pH, and osmotic pressure and water potentials has never
been investigated. It is obvious that the severity would
be obviously seen more in IBS than in the gut conditions
of symptomatic or asymptomatic condition [25].
We fortuitously through field and other clinical surveys
over a length of time collected subtype 3 Blastocystis from
three different groups, asymptomatic individuals, symptom-
atic and IBS patients and in the present study attempt to
evaluate if the parasite from these three different gut condi-
tions can influence phenotypic variation of the parasite.
Methods
Source of Blastocystis isolates
A total of 8 Blastocystis isolates were obtained from four
IBS patients (IBS1-4) and four symptomatic patients
(S1-4) at a local gastroenterology clinic. Asymptomatic
isolates (A1-4) were obtained from a field survey at a local
village. Irritable bowel syndrome was defined according
to the Rome III criteria [26] whereas gastrointestinal
symptoms which varied from stomach bloating, diar-
rhoea, abdominal cramp to excessive gas. Stool screening
were also done for various intestinal parasites such as
Entamoeba histolytica, Giardia lamblia, microsporidia,
Dientamoeba fragilis, Ascaris lumbricoides, Trichuris
trichiura, hookworm and Taenia sp. Patients who were
positive for one or more of these parasites was excluded
from the present study.
The parasites were isolated by culturing in 3 ml
Jones’ medium supplemented with 10% horse serum
(Gibco Laboratories, Life Technologies) and maintained at
37°C. The positive cultures were sub-cultured once every
three days and also stored at −20°C for subsequent
subtyping. Consequently after isolation, the parasites were
maintained in Jones’ medium supplemented with 10%
horse serum for at least one month prior to the elucida-
tion of phenotypic characteristics.
Subtyping of Blastocystis
The genomic DNA of Blastocystis for all 12 isolates
were extracted using QIAamp DNA stool mini kit
(Qiagen, Hilden, Germany) according to the manufacturers’
protocol. All 12 Blastocystis isolates were then subjected
to sequence tagged site (STS) primer-polymerase chain re-
action (PCR) using the seven sets of primers previously
described by Yoshikawa et al. [18]. Two to five microliters
of DNA preparations were used to amplify the genomic
sequences in a 20 μl reaction containing 1× PCR buffer(Fermentas, USA). PCR condition consisted of 1 cycle of
initial denaturing at 95°C for 5 minutes, followed by 40 cy-
cles of denaturing at 95°C for 1 minute, annealing at 56.3°C
for 1 minute 30 seconds and extending at 72°C for 1 minute,
and an additional cycle of elongation at 72°C for 10 minute
(Thermocycler Bio-Rad). The amplified products were then
electrophoresed in 1.5% agarose gels (Promega, USA) in
Tris–borate-EDTA buffer. Gels were stained with ethidium
bromide and photographed using an ultraviolet gel docu-
mentation system (Uvitec, United Kingdom). PCR amplifi-
cation for each primer pair were done in triplicate.
Growth characteristics of Blastocystis
The parasites of each isolate were pooled together from
day 3 cultures to make a final concentration of 1x104
Blastocystis per ml in 3 ml screw-capped tubes containing
Jones’ medium supplemented with 10% horse serum.
All cultures were kept in airtight screw- capped
tubes and incubated at 37°C for up to 10 days. All
experiments were done in triplicates. The Blastocystis
count was carried out using haemocytometer chamber
(Improved Neubauer, Hausser Scientific) with 0.4% trypan
blue dye exclusion (Sigma-Aldrich Corp. USA) as viability
indicator. The parasite count was determined daily in
cultures until it became non-viable. Only viable cells
that did not take up trypan blue stain were counted.
Fifty parasites were randomly chosen from every culture
tube for size measurement every 2 day culture period for
the next 10 days. Statistical analysis was carried out using
SPSS version 21. Generation time (GT) was calculated
for the 24-h period during the most rapid growth based





3:3 log b=Bð Þ ; where
B ¼ number of cells at zero time
b ¼ number of cells at end of time period
t ¼ time period
GT ¼ generation time
n ¼ number of generations
log ¼ logarithm to the base 10 common logð Þ
Modified fields’ stain
The Blastocystis isolates from day 3 culture were stained
with Modified Fields’ stain according to the protocol by
Afzan [28]. The slides were then viewed under 400X mag-
nification. All experiments were done in triplicates.
Cytochemical staining
The parasites were then grown, pooled and centri-
fuged respectively to make smears on day 3 cultures
with Fluorescein isothiocyanate (FITC)-labelled Con
A (Canavalia ensiformis) [16] and examined with a
Figure 1 Genotyping of Blastocystis isolates isolated from
asymptomatic individuals L1-L4, symptomatic isolates L5-L8, and
IBS isolates L9-12, ST 3 (526 bp), M= 100 bp plus DNA marker.
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incident light transmission at 400X magnification. All
experiments were done in duplicate. The results were
then quantified by using percentage of fluorescent cells in
100 cells and affinity fluorescence unit (AFU) (scale of
brightness of 1+, 2+, 3+ and 4+).
Scanning electron microscopy
The parasites were washed three times with phosphate
buffered saline (PBS) pH 7.4. The samples were centri-
fuged at 2000 × g for 5 min. The pelleted cells were fixed
with 4% glutaraldehyde and post-fixed with 1% osmium
tetroxide. The specimens were then mounted on poly-
carbonate membrane (Nuclipore, Agar Scientific, USA)
and dehydrated in increasing concentrations of ethanol
(30%, 50%, 70%, 80%, 90% and 100%). The specimens
were critical-point dried with carbon dioxide coated with
gold, and examined with a scanning electron microscope
(FEI-Quanta 200 FESEM, USA).
Transmission electron microscopy
Culture containing Blastocystis was collected from day 3
culture washed three times using PBS pH 7.4 and cen-
trifuged at 2000× g, for 5 min. The pelleted cells were
re-suspended overnight in 4% glutaraldehyde in 0.1 M
sodium cacodylate buffer, pH 7.3 at 4°C, washed thoroughly
with cacodylate buffer and post-fixed for 30 min in 1%
osmium tetroxide in cacodylate buffer. The fixed cells were
dehydrated for 5 minutes in ascending series of ethanols
(30%, 50%, 70%, 80%, 90% and 100%) and embedded in
epoxy resin. Semithin sections were stained with toluidine
blue. Ultrathin sections were cut using an ultramicrotome,
contrasted with uranyl acetate and lead citrate and viewed
using a transmission electron microscope (LEO Libra120).
Results
Genotyping of Blastocystis
Based on PCR amplification with the STS primers, all the
12 isolates from 3 different groups, asymptomatic, symp-
tomatic and IBS isolates amplified with the primer SB227
(~526 bp) [18] (Figure 1). The PCR products for all three
groups were determined as subtype 3 (ST3). In this study,
we found that subtype 3, which also known as pathogenic
subtype is also found in the asymptomatic isolates.
Growth characteristics
A total of 12 Blastocystis ST3 isolates from four IBS
patients (IBS1-4), symptomatic patients (S1-4) and
asymptomatic individuals (A1-4) respectively were used
in the present study. The growth profile with an initial
inoculation of 1.0X104 cells/ml showed three distinct
and different growth profiles. A1-4 isolates showed the
highest peak growth compared to the other two groups
followed by IBS1-4 isolates and S1-4 isolates. The rangeof parasite count during peak growth in IBS isolates was
between 33.1X104 cells/ml to 112.4X104 cells/ml (Figure 2)
and in symptomatic isolates between 4.53X104 cells/ml to
9.33X104. The parasite peak count for A1-4 isolates ranged
from 120X104 cells/ml in isolate A1 to 496X104 cells/ml in
isolate A2(Figure 2). All IBS isolates peaked on day 5 in-
cluding one and two of the symptomatic and asymptomatic
isolates respectively. The remaining isolates peaked on day
4 with the exception of isolates S2 and A4 which peaked on
day 6 (Figure 2).
The symptomatic isolates (average generation time:
9.87 ± 2.97 h) grew faster than the IBS isolates (average
generation time: 7.56 ± 1.06 h) and asymptomatic iso-
lates (average generation time: 5.97 ± 1.52 h) (Figure 3).
Parasites from IBS isolates (IBS1-4) showed the largest
diameter with a mean of 18.43 ± 2.22 μm compared to para-
sites of symptomatic isolates (isolates S1-4) 15.54 ± 3.02 μm
and asymptomatic isolates (isolates A1-4) 11.76 ± 0.82 μm
(Figure 4).
Modified fields’ stain
The staining characteristics in parasites from all three
groups were similar. However parasites from IBS isolates
showed strong aggregation and clumping (Figure 5C), the
intensity of which was markedly seen reduced in parasites
of isolates S1-4 (Figure 5B). Parasites from A1-4 isolates
were seen to be distinct with no clumping (Figure 5A).
Cytochemical staining of Blastocystis
The outer surface of parasites in IBS isolates (Figure 6C)
showed greater binding affinities towards FITC-labelled
Concanavalin A (Con A) than symptomatic isolates
(Figure 6B) and asymptomatic isolates (Figure 6A). The
fluorescence intensity and the percentage of the reactive
forms of IBS isolates in FITC-labelled Con A stain range
was (4+; 88-100%), symptomatic isolates, S1-4 (3+; 78-100%)
and for asymptomatic isolates, A1-4 (1+; 78- 94%).
Figure 2 Growth profile of Blastocystis isolates A1-4, IBS1-4 and S1-4 in Jones’ medium supplemented with 10% horse serum.
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Blastocystis forms in three different groups, asymp-
tomatic isolates (Figure 7A&B), symptomatic isolates
(Figure 7 B&C) and IBS isolates (Figure 7E&F) appeared to
have different surface respectively. Scanning electron
microscopy showed that Blastocystis isolated from asymp-
tomatic isolates possess a very smooth surface meanwhile
the Blastocystis isolated from symptomatic isolates showed
slightly rough surface with tiny pores. In IBS isolates, the
surface of Blastocystis showed a very coarse and intensely
folded surface.
Ultrastructure of Blastocystis
Blastocystis in all three groups, asymptomatic isolates
(Figure 8A), symptomatic isolates (Figure 8B) and IBS
isolate (Figure 8C-H) appeared to be rounded and oval
shape. The IBS isolates also exhibited a dense material
(Figure 8C-H). In contrast, the dense material was notFigure 3 Comparison between generation time for IBS isolates
(IBS1-4), symptomatic isolates (S1-4) and asymptomatic isolates
(A1-4) of Blastocystis isolates. Note that the asymptomatic isolates
grew faster than both IBS isolates and symptomatic isolates.seen in any of the parasites from both the asymptomatic
and symptomatic isolates.
Blastocystis in IBS isolates (Figure 9C-F) showed a
thicker layer of surface coat surrounding the parasites
compared to a relatively thinner layer seen in both
asymptomatic isolates (Figure 9A) and symptomatic
isolates (Figure 9B).
Discussion
The pathogenicity of Blastocystis is still disputed because of
its presence in both asymptomatic individuals and symp-
tomatic patients [12,29]. Out of 15 subtypes (ST1-ST15)
based on the small subunit rRNA, nine of it had been
found in human (ST1-ST9) [30].
Previous studies have demonstrated that parasites
from symptomatic and asymptomatic isolates have
shown phenotypic differences [16,17] but these differences
could have been largely due to subtype differences. In
the present study, the fortuitous discovery of subtype 3Figure 4 Comparison between average size of parasites for IBS
isolates (IBS1-4), symptomatic isolates (S1-4) and asymptomatic
isolates (A1-4) of Blastocystis isolates.
Figure 5 Comparison of clumping of Blastocystis stained with modified field stain for IBS isolates (IBS1-4), symptomatic isolates (S1-4)
and asymptomatic isolates (A1-4) of Blastocystis isolates. A: A1 isolate were stained with modified field stain and the parasites were far apart;
B: Blastocystis from S2 isolates were attached together in a smaller number of parasite; C: The IBS1 isolate seen to be clumped together in a
large number.
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symptomatic and asymptomatic individuals have been
exploited to assess if differing gut conditions can influ-
ence phenotypic differences.
Growth profiles have been used previously to demon-
strate phenotypic differences [16] and in the present study
three distinct growth profiles and generation time were
seen for symptomatic, asymptomatic and IBS isolates pro-
viding evidence that the rate and possibly the biology of
reproduction could be influenced by gut conditions. The
generation time shows that the asymptomatic isolates
grew faster than symptomatic and IBS isolates which were
similar with a study done by Tan et al. [16]. Furthermore
the IBS isolates are larger in diameter compared to para-
sites from symptomatic and asymptomatic. What is inter-
esting to note is that the size variation in IBS isolates is
the highest compared to the other two groups implying
that the growth conditions in IBS gut would have con-
ferred this diversity in size, growth rate and generation
time. There was a notable clumping of parasites seen in
all isolates from IBS which was absent totally in all asymp-
tomatic isolates and partially seen in symptomatic isolates.
The surface coat of parasites from IBS isolates has been
shown to be folded and coarse as seen by SEM and its sur-
face coat seen more prominently thicker by TEM studies.
It is highly likely that this surface could be sticky which
has resulted in the clumping of the parasites which is seenFigure 6 Comparison of binding affinities of Blastocystis stained with
(S1-4) and asymptomatic isolates (A1-4). C: IBS isolates (IBS1-4) which w
ities with scale brightness of AFU (4+), B: symptomatic isolates, isolates S1-4, A
are expressed as: AFU 1+ weak intensity, AFU 3+ medium intensity, AFU 4+ sin the fields’ stain. The surface coat also showed a high
Con A binding with 88-100% of cells in all IBS isolates
showing affinity fluorescence unit (AFU) of 4+ compared
to symptomatic and asymptomatic isolates which showed
only 3+ and 1+ respectively.
The digestive system’s purpose is to facilitate the break-
down and absorption of nutrients into the bloodstream.
The environment has to be supplemented with the right
gut flora [31], pH [32] and the right amount of secretion
of acid, bile and pancreatic juices [33]. The pH of gastric
acid and small intestine is between pH 1.5 to 3.5 and
pH 7.0 to 9.0 respectively. Recent studies have moved the
belief that IBS is a purely psychological disorder. There
has been clear demonstration of distinct abnormalities of
the gut mucosa including immune activation, increased
release of inflammatory mediators and impaired
gut barrier function. It is obvious that the gut condi-
tions vary between asymptomatic to symptomatic
conditions with prominent differences such as low
grade inflammation, abnormal gases, immunological
response, low fecal microbiota acid level with poorer
protein and carbohydrate metabolism in IBS patients
[34]. Furthermore the gut diversity with increased bacteria
has been reported to be seen within the mucus layer
sometimes in the deeper portions previously reported in
IBS patients using the fluorescent in situ hybridization
method possibly due to a common barrier defect withinFITC-labelled Con A for IBS isolates (IBS1-4), symptomatic isolates
ere stained with FITC-labelled Con A showed a greater binding affin-
FU (3+) and A: asymptomatic isolates, isolates A1-4, AFU (1+). The values
trong intensity (percentage of reactive forms).
Figure 7 Comparison of Scanning electron microscopy of Blastocystis for IBS isolates (IBS1-4), symptomatic isolates (S1-4) and
asymptomatic isolates (A1-4). A & B: Scanning electron microscopy showed that Blastocystis isolated from A1 possess a smooth surface; C & D:
The Blastocystis isolated from symptomatic isolate, S1 showed slightly rough surface; E & F: The Blastocystis isolated from IBS1 showed coarse
and folded surface.
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CD8+, CD4+, LPL and IEL between PI-IBS patients and
healthy controls have been shown providing evidence that
there has been aberrant mucosal immune response to the
luminal environment in PI-IBS [37]. The severity in IBS
conditions and the influence of these adverse changes in
gut condition obviously seem to have a pronounced effect
on the phenotypic expression of Blastocystis seen in the
present study.
Studies have implicated that genotypes of Blastocystis
to be the influencing factors for the parasite’s pathogenicity
especially subtype 3 where in Malaysia [16] Singapore [20]and USA [38] evidence for its pathogenicity was clearly
demonstrated. Blastocystis ST3 was also found to be the
only subtype in 100% of patients suffering from urticaria in
Egypt [39] Blasto-Ag of ST3 showed the most predominant
subtype compared to five other subtypes in triggering a
higher proliferation rate in colorectal cancer cells [40]. Tan
et al. [16] also demonstrated ST3 to be pathogenic when
comparing the phenotypic characteristics between symp-
tomatic and asymptomatic isolates of Blastocystis.
The present study however is the first to demonstrate
phenotypic variation within a subtype 3 population
from three environments namely asymptomatic, IBS
Figure 8 (See legend on next page.)
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Figure 8 Comparison of Transmission electron microscopy for IBS isolates (IBS1-4), symptomatic isolates (S1-4) and asymptomatic
isolates (A1-4). A: Transmission electron micrographs (TEM) shows asymptomatic isolates, isolate A1; B: The Blastocystis isolated from
symptomatic isolates, S1. C-H: Electron dense material can be seen within central body of all IBS isolates. Note: (V) vacuole, (DM) dense material,
(SC) surface coat.
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survival purposes could be a possible reason for the
phenotypic variation to exist.
The thicker surface coat shown by the ultrastructural
study in IBS isolates could influence cytopathic effect
of Blastocystis towards the intestinal lining of the gut.
Blastocystis lysate and live parasite have been shown to
trigger cytopathic effect on Chinese Hamster Ovary
cells [41,42]. The coarse and uneven surface with fold-
ing seen in parasites of IBS isolates showing high Con
A binding as well the aggregation and clumping seen
in stained smears provide evidence that the surface is
sticky. This becomes ideal to facilitate adherence to
bacteria [43] as well as to the intestinal lining which
can exacerbate inflammation.
In IBS condition inflammation of intestinal layer could
cause leaky gut syndrome which facilitates undigested
food substances to pass between the cells of the intes-
tinal epithelial layer to the bloodstream causing damage
on the intestinal wall [44] which in turn will reduce the
efficiency of nutrient absorption. Previous studies have
shown that the interplay between luminal factors such
as food, living bacteria in the intestine, epithelial barrier
and the mucosal immune system can alter structuralFigure 9 Comparison of thickness of surface coat for IBS isolates (IBS1
Blastocystis in IBS isolates (Figure 9C-F) revealed to have a thicker layer
surface coat compared to a relatively thin layer of membrane in both arearrangement of tight junction proteins in the small in-
testine and colon which can result in the increasement
of intestinal permeability especially in post-infectious
IBS and in IBS with diarrhoea [45]. Dietary intake could
also influence the intestinal gut flora causing a digestive
problem which then can lower the immune system [46].
Other than that, a studies done to evaluate the role of
single nucleotide polymorphisms (SNPs) for interleukin
(IL)-8 and IL-10, comparing between IBS patients infected
with Blatoscytsis and asymptomatic patients found out
that it can actually alter individual sensitivity increasing
the relative risk in the development of Blastocystis infected
IBS patients [47].
The present finding has a very important implication.
Previously all evidences have been pointing to subtype 3
to be the pathogenic one. However the present study
cautions on forming such a conclusion and suggest that
ascribing subtype to pathogenicity could be an over
generalization. It is evident that gut environment can in-
fluence phenotypic expression of even the same subtype.
A similar study had been done on assessing the pheno-
typic characterization of entamoeba hystolytica whereby
the interaction between the parasites and host compo-
nent such as bacterial flora and mucins can trigger the-4), symptomatic isolates (S1-4) and asymptomatic isolates (A1-4);
of membrane surrounding the parasites which is also known as
symptomatic isolates and symptomatic isolates (Figure 9A& B).
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lences factor [48].
It is beyond the scope of the present study to postulate
the details of the gut environment although others have
suggested that an unhealthy gut has a complex open ended
ecosystem which can be a host for various microorganisms
[49-51]. These and other factors had made the difference.
The study has diagnostic implications and it is important to
ensure that a proper and a detailed study be undertaken be-
fore forming any definite conclusion as gut environment
does play a part in expressing and influencing phenotypic.
Conclusion
There have been no studies thus far providing evidence
for phenotypic variation within a particular subtype. The
present study is the first to demonstrate the phenomenon
of gut environment facilitating adaptation of parasites
possibly for survival leading to phenotypic differences
for Blastocystis.
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